TPWA
KURA icon

Twin Peaks Wealth Advisors’s Kura Oncology KURA Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-52
Closed -$423 – 1298
2026
Q1 		$423 Buy
+52
New +$447 ﹤0.01% 2057

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Twin Peaks Wealth Advisors's KURA Position: Q2 2026 in Review

Twin Peaks Wealth Advisors sold out of Kura Oncology (KURA) in Q2 2026, closing a stake of 52 shares — an estimated $423 sold.

Twin Peaks Wealth Advisors first reported a position in KURA in Q1 2026 and held it in 1 quarter. The position peaked at $423 in Q1 2026. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Twin Peaks Wealth Advisors reported no remaining Kura Oncology position as of Q2 2026 after selling out during the quarter.
  • Twin Peaks Wealth Advisors sold 52 Kura Oncology shares in Q2 2026, an estimated $423.
  • Twin Peaks Wealth Advisors first reported a position in Kura Oncology in Q1 2026 and held it in 1 quarter.
  • Twin Peaks Wealth Advisors's Kura Oncology position peaked at $423 in Q1 2026.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.